These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 39237980)

  • 1. Neuroprotective effects of intranasal extracellular vesicles from human platelet concentrates supernatants in traumatic brain injury and Parkinson's disease models.
    Delila L; Nebie O; Le NTN; Timmerman K; Lee DY; Wu YW; Chou ML; Buée L; Chou SY; Blum D; Devos D; Burnouf T
    J Biomed Sci; 2024 Sep; 31(1):87. PubMed ID: 39237980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates.
    Nebie O; Devos D; Vingtdeux V; Barro L; Devedjian JC; Jonneaux A; Chou ML; Bordet R; Buée L; Knutson F; Blum D; Burnouf T
    J Biomed Sci; 2019 Oct; 26(1):89. PubMed ID: 31666073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human platelet lysate biotherapy for traumatic brain injury: preclinical assessment.
    Nebie O; Carvalho K; Barro L; Delila L; Faivre E; Renn TY; Chou ML; Wu YW; Nyam-Erdene A; Chou SY; Buée L; Hu CJ; Peng CW; Devos D; Blum D; Burnouf T
    Brain; 2021 Nov; 144(10):3142-3158. PubMed ID: 34086871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of platelet extracellular vesicles (PEVs) for corneal endothelial regeneration.
    Widyaningrum R; Wu YW; Delila L; Lee DY; Wang TJ; Burnouf T
    Platelets; 2022 Nov; 33(8):1237-1250. PubMed ID: 35949054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective activity of a virus-safe nanofiltered human platelet lysate depleted of extracellular vesicles in Parkinson's disease and traumatic brain injury models.
    Delila L; Nebie O; Le NTN; Barro L; Chou ML; Wu YW; Watanabe N; Takahara M; Buée L; Blum D; Devos D; Burnouf T
    Bioeng Transl Med; 2023 Jan; 8(1):e10360. PubMed ID: 36684076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tailor-made purified human platelet lysate concentrated in neurotrophins for treatment of Parkinson's disease.
    Chou ML; Wu JW; Gouel F; Jonneaux A; Timmerman K; Renn TY; Laloux C; Chang HM; Lin LT; Devedjian JC; Devos D; Burnouf T
    Biomaterials; 2017 Oct; 142():77-89. PubMed ID: 28728000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Umbilical cord blood-derived exosomes attenuate dopaminergic neuron damage of Parkinson's disease mouse model.
    Ye J; Sun X; Jiang Q; Gui J; Feng S; Qin B; Xie L; Guo A; Dong J; Sang M
    J Nanobiotechnology; 2024 Sep; 22(1):567. PubMed ID: 39277761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization.
    Wu YW; Lee DY; Lu YL; Delila L; Nebie O; Barro L; Changou CA; Lu LS; Goubran H; Burnouf T
    Platelets; 2023 Dec; 34(1):2237134. PubMed ID: 37580876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and Chromatographic Isolation of Platelet Extracellular Vesicles from Human Platelet Lysates for Applications in Neuroregenerative Medicine.
    Nyam-Erdene A; Nebie O; Delila L; Buée L; Devos D; Chou SY; Blum D; Burnouf T
    ACS Biomater Sci Eng; 2021 Dec; 7(12):5823-5835. PubMed ID: 34846835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-derived extracellular vesicles released after trauma promote hemostasis and contribute to DVT in mice.
    Dyer MR; Alexander W; Hassoune A; Chen Q; Brzoska T; Alvikas J; Liu Y; Haldeman S; Plautz W; Loughran P; Li H; Boone B; Sadovsky Y; Sundd P; Zuckerbraun BS; Neal MD
    J Thromb Haemost; 2019 Oct; 17(10):1733-1745. PubMed ID: 31294514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-derived- Extracellular Vesicles Promote Hemostasis and Prevent the Development of Hemorrhagic Shock.
    Lopez E; Srivastava AK; Burchfield J; Wang YW; Cardenas JC; Togarrati PP; Miyazawa B; Gonzalez E; Holcomb JB; Pati S; Wade CE
    Sci Rep; 2019 Nov; 9(1):17676. PubMed ID: 31776369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Potential Neuroprotective Effects of Vanillin Against MPP
    Rani L; Ghosh B; Ahmad MH; Mondal AC
    Mol Neurobiol; 2023 Aug; 60(8):4693-4715. PubMed ID: 37145378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can the administration of platelet lysates to the brain help treat neurological disorders?
    Nebie O; Buée L; Blum D; Burnouf T
    Cell Mol Life Sci; 2022 Jun; 79(7):379. PubMed ID: 35750991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel antagonist of p75NTR reduces peripheral expansion and CNS trafficking of pro-inflammatory monocytes and spares function after traumatic brain injury.
    Lee S; Mattingly A; Lin A; Sacramento J; Mannent L; Castel MN; Canolle B; Delbary-Gossart S; Ferzaz B; Morganti JM; Rosi S; Ferguson AR; Manley GT; Bresnahan JC; Beattie MS
    J Neuroinflammation; 2016 Apr; 13(1):88. PubMed ID: 27102880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.
    Ghosh A; Kanthasamy A; Joseph J; Anantharam V; Srivastava P; Dranka BP; Kalyanaraman B; Kanthasamy AG
    J Neuroinflammation; 2012 Oct; 9():241. PubMed ID: 23092448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
    Pariyar R; Bastola T; Lee DH; Seo J
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease.
    Prediger RD; Aguiar AS; Moreira EL; Matheus FC; Castro AA; Walz R; De Bem AF; Latini A; Tasca CI; Farina M; Raisman-Vozari R
    Curr Pharm Des; 2011; 17(5):489-507. PubMed ID: 21375482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Amniotic Epithelial Cells Alleviate a Mouse Model of Parkinson's Disease Mainly by Neuroprotective, Anti-Oxidative and Anti-Inflammatory Factors.
    Zhang J; Li H; Yang H; Lin J; Wang Y; Zhang Q; Gao WQ; Xu H
    J Neuroimmune Pharmacol; 2021 Sep; 16(3):620-633. PubMed ID: 33164162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling.
    Fujita A; Fujita Y; Pu Y; Chang L; Hashimoto K
    Psychopharmacology (Berl); 2020 Jan; 237(1):83-92. PubMed ID: 31418048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and evaluation of mucoadhesive microemulsion for neuroprotective effect of ibuprofen following intranasal route in the MPTP mice model.
    Mandal S; Mandal SD; Chuttani K; Sawant KK; Subudhi BB
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1340-50. PubMed ID: 26710671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.